Heparan-sulfate proteoglycans found to influence Alzheimer’s cell pathology

FHS
July 5, 2024
9:23 am

The impact of heparan-sulfate-modified proteoglycans (HSPGs) on Alzheimer’s disease-associated pathways.

Opinion | Healthcare Isn’t ‘Broken’ — It’s Fragmented

Yurkiewicz is an oncologist and internal medicine physician. A few years ago, I was the oncology doctor on call when I was paged about a

September 11, 2023

Signal: UK clinical research provider Ergomed bought out in $888m deal – Pharmaceutical Technology

Private equity fund Permira has announced that it is acquiring Ergomed. Photo: T. Schneider / Shutterstock. UK private equity firm Permira has announced an agreement

September 4, 2023

Colorado blames Biden team and drugmakers for delaying Canadian imports

Colorado officials say their plan to import cheaper medicines from Canada has been stymied by opposition from drugmakers and inaction by the Biden administration, according

December 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.